Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and characterisation of SMURF2-targeting modifiers.
J Enzyme Inhib Med Chem. 2021 Dec;36(1):401-409. doi: 10.1080/14756366.2020.1871337.
J Enzyme Inhib Med Chem. 2021.
PMID: 33430646
Free PMC article.
Inhibiting the copper efflux system in microbes as a novel approach for developing antibiotics.
Meir A, Lepechkin-Zilbermintz V, Kahremany S, Schwerdtfeger F, Gevorkyan-Airapetov L, Munder A, Viskind O, Gruzman A, Ruthstein S.
Meir A, et al. Among authors: lepechkin zilbermintz v.
PLoS One. 2019 Dec 30;14(12):e0227070. doi: 10.1371/journal.pone.0227070. eCollection 2019.
PLoS One. 2019.
PMID: 31887125
Free PMC article.
Item in Clipboard
Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators.
Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A.
Lepechkin-Zilbermintz V, et al.
Bioorg Med Chem. 2023 May 3;87:117303. doi: 10.1016/j.bmc.2023.117303. Epub 2023 May 3.
Bioorg Med Chem. 2023.
PMID: 37167713
Item in Clipboard
Cite
Cite